Answers are grounded in this paper and cite their sources.
Chronic myelomonocytic leukemia (CMML) is a malignant myeloid stem cell disease accompanied by dysplasia in the context of myeloproliferative disease.Peripheral cytopenias (mainly anemia and thrombocytopenia) and hepatosplenomegaly are common fi ndings.Dramatic leukocytosis can also be seen without transformation to acute myeloid leukemia (AML); in some cases, this leukocytosis is associated with leukostasis and end organ damage.Splenomegaly is present in up to 25 percent of patients with CMML and is often accompanied by hepatomegaly, lymphadenopathy, or nodular cutaneous leukemic infi ltrates.Gingival infi ltration is occasionally observed but is much rarer than in AML with monocytic differentiation; central nervous system involvement is rare.Pleural and pericardial effusions and ascites can occur in CMML with very high monocyte counts and these signs often resolve with antileukemic therapy.Constitutional symptoms (ie, fevers, unexplained weight loss, and night sweats) are seen in some CMML cases and are similar to the symptoms associated with primary myelofi brosis.The acquired cogulation defect may be due to factor X binding to atypical monocytes,resulting with acquired factor X defi ciency.We report this case of CMML , who presented symptomatic multiple hemorrhagic skin lesions, echimosis and hematomas.Despite the rarity, Dissemine intravascular coagulation (DIC) may be presenting clinical feature for CMML.The treatment is challenging and considering the high risk of bleeding because of thrombocytopenia, acute Dissemine intravascular coagulation (DIC) also aggrevates the complications.
No takes yet. Share an insight, caveat, or question.
Demiriz Itir Sirinoglu (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: